Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism?
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-02-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/2/e010806.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1825206905315786752 |
|---|---|
| author | Gianluca Azzellino Lia Ginaldi Massimo De Martinis |
| author_facet | Gianluca Azzellino Lia Ginaldi Massimo De Martinis |
| author_sort | Gianluca Azzellino |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d5706396a8084588b45e98eb15610488 |
| institution | Kabale University |
| issn | 2051-1426 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj-art-d5706396a8084588b45e98eb156104882025-02-07T04:55:09ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262025-02-0113210.1136/jitc-2024-010806Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism?Gianluca Azzellino0Lia Ginaldi1Massimo De Martinis2University of L`Aquila Department of Clinical Medicine Public Health Life Sciences and Environment, L`Aquila, Abruzzo, ItalyUniversity of L`Aquila Department of Clinical Medicine Public Health Life Sciences and Environment, L`Aquila, Abruzzo, ItalyUniversity of L`Aquila Department of Clinical Medicine Public Health Life Sciences and Environment, L`Aquila, Abruzzo, Italyhttps://jitc.bmj.com/content/13/2/e010806.full |
| spellingShingle | Gianluca Azzellino Lia Ginaldi Massimo De Martinis Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism? Journal for ImmunoTherapy of Cancer |
| title | Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism? |
| title_full | Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism? |
| title_fullStr | Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism? |
| title_full_unstemmed | Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism? |
| title_short | Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism? |
| title_sort | targeting il 33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism |
| url | https://jitc.bmj.com/content/13/2/e010806.full |
| work_keys_str_mv | AT gianlucaazzellino targetingil33inpatientswithcancerunderimmunecheckpointinhibitorsforabetterantitumorresponseandpreventthromboembolism AT liaginaldi targetingil33inpatientswithcancerunderimmunecheckpointinhibitorsforabetterantitumorresponseandpreventthromboembolism AT massimodemartinis targetingil33inpatientswithcancerunderimmunecheckpointinhibitorsforabetterantitumorresponseandpreventthromboembolism |